Skip to main content
. 2014 Jan 28;11(2):402–410. doi: 10.4314/ajtcam.v11i2.26

Table 5.

Effect of HEAC on liver antioxidant system, lysosomal enzymes and glycoprotein in CFA-induced arthritic rats

Treatment GSH (U/mg
protein)
SOD (U/mg
protein)
CAT (U/mg
protein)
MDA (ng/mg
protein)
Nitrite Hexose
sugar
Sialic Acid
phosphatase
(U/l)
Prostatic
phosphatase
(U/l)
Untreated control 1.38 ± 0.20 1.89 ± 0.16 13.27 ± 2.67 0.02 ± 0.00 8.62 ±
1.24
522.90 ±
10.17
199.70 ±
2.58
67.20 ±
11.77
60.50±13.43
Arthritic control 1.07 ± 0.22d 1.09 ± 0.10d 12.34 ± 0.92 0.09 ± 0.00c 11.17 ±
0.77
676.40 ±
7.49
378.70 ±
5.92c
134.10 ±
10.96c
94.71±2.36a
100 mg/kg
HEAC (Pre)
1.19 ± 0.15a 2.10 ± 0.52 a 13.00 ± 1.15 0.02 ± 0.00d 7.09 ±
0.50
558.90 ±
16.93
338.80 ±
4.30b
76.02 ±
18.68e
53.93±10.61d
200 mg/kg
HEAC (Pre)
1.59 ± 0.15 a 2.14 ± 0.50a 14.39 ± 2.03 0.02 ± 0.00d 10.53 ±
1.68
576.50 ±
53.33
199.70 ±
22.52e
79.29 ±
2.12e
41.34±1.04e
400 mg/kg
HEAC (Pre)
1.36 ± 0.19a 4.00 ± 0.20b 15.39 ± 2.03 0.03 ± 0.01d 7.98 ±
0.67
462.00 ±
14.91e
81.78 ±
10.11f
63.05±10.22e 68.34±3.38d
200 mg/kg
HEAC (Post)
1.48 ± 0.19a 1.61 ± 0.15 17.03 ± 1.00 0.06 ± 0.02 10.32 ±
1.19
855.00 ±
71.66b
318.80 ±
39.54b, d
74.23±1.80e 63.36±0.24d
400 mg/kg
HEAC (Post)
2.48 ± 0.46c 3.03 ± 0.60b 15.36 ± 2.85 0.04 ± 0.00d 10.76 ±
0.07
515.50 ±
61.77d
250.50 ±
18.68a, d
75.28±14.61e 79.05±1.08d
3 mg/kg CELE 1.66 ± 0.27a 1.54 ± 0.35 8.72 ± 0.63 0.02 ± 0.002d 10.78 ±
0.29
536.80 ±
7.86
235.60 ±
13.97a, d
42.96±7.19f 21.75±1.06f
a, b and c

represent significant increases at p<0.05, p<0.01 and p<0.001, respectively, when compared to untreated control. d, e and f represent significant decreases at p<0.05, p<0.01 and p<0.001 when compared to arthritic control values